000 03079nam a22003975i 4500
001 82309
003 ES-MaUEC
005 20230207040406.0
007 cr nn 008mamaa
008 150526s2015 gw | s |||| 0|eng d
020 _a9783319148717
024 7 _a10.1007/978-3-319-14871-7
_2doi
050 4 _aRC694.5.I53
_b2015 EB
100 1 _aWatts, Richard A.
_94198
_0comprobar BNE19900033073
245 1 0 _aVasculitis in Clinical Practice
_cby Richard A. Watts, David G. I. Scott, Chetan Mukhtyar.
250 _a2nd ed. 2015.
260 _aCham, Switzerland
_bSpringer
_c2015
300 _a1 recurso en línea (XX, 220 páginas)
_b45 ilustraciones, 34 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aPart 1. Introduction -- 1. Definitions -- 2. Classification and Epidemiology -- 3. General Presentation of the Vasculitides -- 4. General Principles of Treatment -- Part 2. Features of Individual Diseases -- 5. Giant Cell Arteritis -- 6. Takayasu Arteritis -- 7. Granulomatosis with Polyangiitis - GPA (Wegeners) -- 8. Eosinophilia with Granulomatosis and Polyangiitis- EGPA (Churgâ€{u3D32}auss Syndrome) -- 9. Microscopic Polyangiitis -- 10. Polyarteritis Nodosa -- 11. Kawasaki Disease -- 12. IgA Vasculitis -- 13. BehÃ{u00A7}etâ€{u3804}isease -- 14. Cryoglobulinemic Vasculitis -- 15. Vasculitis Mimics -- 16. Secondary Vasculitis -- 17. Primary Angiitis of the Central Nervous System Vasculitis -- 18. Relapsing Polychondritis -- 19. Cogan's Syndrome -- 20. IgG4 Related Disease.
520 3 _aIn this second edition, the authors discuss the newly discovered entity of IgG4 related diseases, look in greater detail at the role of biologic treatment in ANCA associated vasculitis, and have revised the nomenclature in each chapter to reflect international consensus. The addition of illustrations as well as online video content helps the reader manage patients with these potentially devastating conditions. Vasculitis in Clinical Practice, Second Edition, is a useful and concise volume that will help physicians in training, primary care physicians and nurse practitioners in quickly and easily recognizing the key and salient points of each condition.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
650 7 _aAlergia
_2embne
_9138329
650 7 _aReumatología
_2embne
_9141883
650 2 7 _aReumatología
_2embne
_9141883
700 1 _aScott, David G. I.
_995153
_0Local
700 1 _aMukhtyar, Chetan.
_995154
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-14871-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b1290949x
_b10-10-17
_c10-02-16
988 _aSpringer_Medicine_2015
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRC694.5.I53 W388 2015 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11577174
_z06-04-17
999 _c82309
_d82309
_x1